Scientists from the University of Southern California Stem Cell lab of Francesca Mariani, Ph.D., have discovered how the vertebrate ribcage – which supports the body, protects the internal organs and enables life on lan d – develops.
You are here
Coverage of the latest news and updates from the field of stem cells.
A stem cell-derived in vitro model displays key small intestine characteristics including innate immune responses, according to a study by Ying Chen, Ph.D., and David Kaplan, Ph.D., from Tufts University (Boston, Massachusetts) and colleagues.
A team of researchers has illuminated an important role for different subtypes of muscle cells in orchestrating the process of tissue regeneration.
A new study led by researchers at Sanford Burnham Prebys Medical Discovery Institute (SBP) identifies a signaling pathway that is essential for angiogenesis, the growth of new blood vessels from pre-existing vessels.
Researchers report the unexpected finding that selectively deleting a stem cell transcription factor in adult mice promotes recovery after traumatic brain injury (TBI).
A research group at Lund University in Sweden has found that when the HLF (hepatic leukemia factor) gene – which is expressed in immature blood cells – does not shut down on time, we are unable to develop a functional long-term immune system. This could be a very early stage of leukemia.
Paving the way for testing experimental drugs in more realistic environments, scientists at the National Institute of Standards and Technology (NIST) have discovered how to make tiny colonies of cells grow in useful new ways inside petri dishes.
The more than 200 different types of human cells have the same DNA but express different ensembles of genes. Each cell type was derived from embryonic stem cells, which are called pluripotent stem cells because they can differentiate to all those different cell fates.
Cornell University researchers have taken a major step toward answering a key question in cancer research: Why is testicular cancer so responsive to chemotherapy, even after it metastasizes?
Researchers at Boston Children's Hospital have successfully reversed type 1 diabetes in a mouse model by infusing blood stem cells pre-treated to produce more of a protein called PD-L1, which is deficient in mice (and people) with type 1 diabetes.